Empower™
Hereditary cancer testing, made accessible
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis.
Empower screens for genes associated with increased risk for common hereditary cancers. Our Empower multi-cancer panels include commonly screened-for genes associated with 12+ types of cancer.
Get Ahead of Cancer: How Previvors Protect Their Health
Cancer previvors are healthy people who know they inherited a high risk for cancer, and can take action to lower their risk. Genetic risk for certain cancers runs in families, dramatically increasing a person’s lifetime risk for developing cancer. If you know you’re at risk, you can take steps to get ahead of cancer.
The Empower™ Hereditary Cancer Test screens your DNA for a wide range of gene variants that are known to impact risk for multiple kinds of cancer. Ask your clinician if Empower is right for you and your family.
Listen to Previvor Stories
Know your risk
Approximately 5 to 10 percent of all cancers can be attributed to inherited variants or mutations. Patterns of cancer can be seen in families where people have these mutations. If you are concerned about cancer patterns in your family, genetic testing can give you more information.
Move Forward With Confidence
The Empower hereditary cancer test analyzes your DNA for genes that could increase your cancer risk or impact cancer treatment.
Megan Trimble - Cancer Previvor, Lynch Syndrome Carrier
How it works
Provider orders an Empower Hereditary Cancer Test.
Patient provides a blood or saliva sample.
Patients review results with their provider within 2 weeks.
Understand your results : There are three possible results from the Empower test
Negative
No variants known to increase risk for cancer were detected in the genes analyzed. You should speak with your provider to assess your risk based on your personal and family health history.
Positive
A variant was found which may be associated with an increased risk for certain cancer types. You should speak with your provider about your results and continue to follow their recommendations. In some cases, there may be implications for cancer treatment.
VUS
A variant has been identified but there is not enough information to determine whether it increases cancer risk or impacts treatment decisions. Variant of Uncertain Significance (VUS) status may change as research progresses. You should speak with your healthcare provider to assess your risk based on your personal and family history.
Commitment to affordability
Natera is proud to be an in-network provider with most health plans, including Anthem, Cigna, and UnitedHealthcare. The cost of Empower varies according to the screening panel selected and your specific insurance coverage. For patients without adequate insurance coverage, Natera also offers self-pay pricing and compassionate care options.
Family Testing Program
*Order must be received within 90 days of original report date. Panel must be the same size or smaller compared to previous relative’s test order. Not available to family members covered by government insurance plans.